Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Divi’s Laboratories has submitted the details as required under Para B of Part A of Schedule III of the Regulations read with Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
The above information is a part of company’s filings submitted to BSE.